M Willingham
Overview
Explore the profile of M Willingham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Willingham M, Ben Abdallah A, Gradwohl S, Helsten D, Lin N, Villafranca A, et al.
Br J Anaesth
. 2014 May;
113(6):1001-8.
PMID: 24852500
Background: Low bispectral index values frequently reflect EEG suppression and have been associated with postoperative mortality. This study investigated whether intraoperative EEG suppression was an independent predictor of 90 day...
2.
Stewart 4th J, Ahmed M, Northrup S, Willingham M, Lyles D
Cancer Gene Ther
. 2011 Sep;
18(12):837-49.
PMID: 21886191
M protein mutant vesicular stomatitis virus is an attractive candidate oncolytic virus for the treatment of metastatic colorectal cancer due to its ability to kill cancer cells that are defective...
3.
Onda M, Willingham M, Wang Q, Kreitman R, Tsutsumi Y, Nagata S, et al.
J Immunol
. 2000 Dec;
165(12):7150-6.
PMID: 11120846
LMB-2 (anti-Tac(Fv)-PE38) is a recombinant immunotoxin composed of the Fv fragment of the anti-Tac Ab fused to a 38-kDa form of Pseudomonas: exotoxin A. Recent clinical trials showed that LMB-2...
4.
Pinkerton S, Holtgrave D, Willingham M, Goldstein E
AIDS Public Policy J
. 2000 Jul;
13(3):115-27.
PMID: 10915279
No abstract available.
5.
Pinkerton S, Holtgrave D, Valdiserri R, Willingham M
J Community Health
. 2000 May;
25(2):95-112.
PMID: 10794204
Since 1994, the Centers for Disease Control and Prevention has required that the 65 health department grantees that receive funding for HIV prevention interventions engage in a community planning process...
6.
Frankel A, Ramage J, Latimer A, Feely T, Delatte S, Hall P, et al.
Protein Expr Purif
. 1999 May;
16(1):190-201.
PMID: 10336877
A genetically engineered fusion toxin targeted to acute myeloid leukemic (AML) blasts was designed with the first 388 amino acid residues of diphtheria toxin with an H-M linker fused to...
7.
Frankel A, Hall P, Burbage C, Vesely J, Willingham M, Bhalla K, et al.
Blood
. 1997 Nov;
90(9):3654-61.
PMID: 9345050
It has previously been shown that human granulocyte-macrophage colony-stimulating factor (GM-CSF) can be fused to a truncated diphtheria toxin (DT) to produce a recombinant fusion toxin that kills GM-CSF receptor-bearing...
8.
Tagge E, Harris B, Burbage C, Hall P, Vesely J, Willingham M, et al.
Bioconjug Chem
. 1997 Nov;
8(5):743-50.
PMID: 9327140
We performed genetic engineering to fuse enhanced green fluorescent protein (EGFP) to the N terminus of RTA, expressed the fusion protein in Escherichia coli, purified and reassociated EGFP-RTA with plant...
9.
Fu T, Burbage C, Tagge E, Chandler J, Willingham M, Frankel A
Bioconjug Chem
. 1996 Nov;
7(6):651-8.
PMID: 8950484
Ricin toxin, the heterodimeric 65 kDa glycoprotein synthesized in castor bean seeds, contains a cell binding lectin subunit (RTB) disulfide linked to an RNA N-glycosidase protein synthesis-inactivating subunit (RTA). Investigations...
10.
Frankel A, Burbage C, Fu T, Tagge E, Chandler J, Willingham M
Protein Eng
. 1996 Oct;
9(10):913-9.
PMID: 8931131
Fusion toxins are hybrid proteins consisting of peptide ligands linked through amide bonds to polypeptide toxins. The ligand directs the molecule to the surface of target cells and the toxin...